Annual EBITDA
-$268.58 M
-$11.64 M-4.53%
31 December 2023
Summary:
Sana Biotechnology annual earnings before interest, taxes, depreciation & amortization is currently -$268.58 million, with the most recent change of -$11.64 million (-4.53%) on 31 December 2023. During the last 3 years, it has risen by +$11.64 million (+4.16%). SANA annual EBITDA is now -92.77% below its all-time high of -$139.33 million, reached on 31 December 2019.SANA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$57.70 M
-$12.23 M-26.89%
30 September 2024
Summary:
Sana Biotechnology quarterly earnings before interest, taxes, depreciation & amortization is currently -$57.70 million, with the most recent change of -$12.23 million (-26.89%) on 30 September 2024. Over the past year, it has dropped by -$60.02 million (-2589.39%). SANA quarterly EBITDA is now -372.73% below its all-time high of $21.16 million, reached on 30 June 2021.SANA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$289.51 M
-$60.02 M-26.15%
30 September 2024
Summary:
Sana Biotechnology TTM earnings before interest, taxes, depreciation & amortization is currently -$289.51 million, with the most recent change of -$60.02 million (-26.15%) on 30 September 2024. Over the past year, it has dropped by -$22.69 million (-8.50%). SANA TTM EBITDA is now -557.03% below its all-time high of -$44.06 million, reached on 31 December 2019.SANA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SANA EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -4.5% | -2589.4% | -8.5% |
3 y3 years | +4.2% | +28.4% | +17.1% |
5 y5 years | - | - | - |
SANA EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -4.5% | +22.3% | -2589.4% | +48.4% | -48.2% | +17.6% |
5 y | 5 years | -92.8% | +22.3% | -372.7% | +67.7% | -557.0% | +32.1% |
alltime | all time | -92.8% | +22.3% | -372.7% | +67.7% | -557.0% | +32.1% |
Sana Biotechnology EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$57.70 M(+26.9%) | -$289.51 M(+26.2%) |
June 2024 | - | -$45.48 M(-57.5%) | -$229.49 M(-22.4%) |
Mar 2024 | - | -$106.98 M(+34.8%) | -$295.86 M(+10.2%) |
Dec 2023 | -$268.58 M(+4.5%) | -$79.36 M(-3523.4%) | -$268.58 M(+0.7%) |
Sept 2023 | - | $2.32 M(-102.1%) | -$266.82 M(-24.0%) |
June 2023 | - | -$111.84 M(+40.3%) | -$351.31 M(+13.8%) |
Mar 2023 | - | -$79.71 M(+2.7%) | -$308.57 M(+20.1%) |
Dec 2022 | -$256.94 M | -$77.59 M(-5.6%) | -$256.94 M(-10.6%) |
Sept 2022 | - | -$82.17 M(+18.9%) | -$287.29 M(+0.6%) |
June 2022 | - | -$69.10 M(+146.2%) | -$285.67 M(+46.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$28.07 M(-74.0%) | -$195.41 M(-43.5%) |
Dec 2021 | -$345.84 M(+23.4%) | -$107.94 M(+34.0%) | -$345.84 M(-1.0%) |
Sept 2021 | - | -$80.55 M(-480.7%) | -$349.46 M(+9.5%) |
June 2021 | - | $21.16 M(-111.9%) | -$319.04 M(-25.2%) |
Mar 2021 | - | -$178.50 M(+60.0%) | -$426.72 M(+52.3%) |
Dec 2020 | -$280.23 M(+101.1%) | -$111.57 M(+122.6%) | -$280.23 M(+31.7%) |
Sept 2020 | - | -$50.12 M(-42.1%) | -$212.72 M(+30.8%) |
June 2020 | - | -$86.53 M(+170.3%) | -$162.60 M(+113.7%) |
Mar 2020 | - | -$32.01 M(-27.4%) | -$76.07 M(+72.6%) |
Dec 2019 | -$139.33 M | -$44.06 M | -$44.06 M |
FAQ
- What is Sana Biotechnology annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Sana Biotechnology?
- What is Sana Biotechnology annual EBITDA year-on-year change?
- What is Sana Biotechnology quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Sana Biotechnology?
- What is Sana Biotechnology quarterly EBITDA year-on-year change?
- What is Sana Biotechnology TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Sana Biotechnology?
- What is Sana Biotechnology TTM EBITDA year-on-year change?
What is Sana Biotechnology annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SANA is -$268.58 M
What is the all time high annual EBITDA for Sana Biotechnology?
Sana Biotechnology all-time high annual earnings before interest, taxes, depreciation & amortization is -$139.33 M
What is Sana Biotechnology annual EBITDA year-on-year change?
Over the past year, SANA annual earnings before interest, taxes, depreciation & amortization has changed by -$11.64 M (-4.53%)
What is Sana Biotechnology quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SANA is -$57.70 M
What is the all time high quarterly EBITDA for Sana Biotechnology?
Sana Biotechnology all-time high quarterly earnings before interest, taxes, depreciation & amortization is $21.16 M
What is Sana Biotechnology quarterly EBITDA year-on-year change?
Over the past year, SANA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$60.02 M (-2589.39%)
What is Sana Biotechnology TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SANA is -$289.51 M
What is the all time high TTM EBITDA for Sana Biotechnology?
Sana Biotechnology all-time high TTM earnings before interest, taxes, depreciation & amortization is -$44.06 M
What is Sana Biotechnology TTM EBITDA year-on-year change?
Over the past year, SANA TTM earnings before interest, taxes, depreciation & amortization has changed by -$22.69 M (-8.50%)